首页> 外文期刊>Cell >Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
【24h】

Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis

机译:丝氨酸蛋白酶抑制剂促进脑转移中的癌细胞存活和血管共选项。

获取原文
获取原文并翻译 | 示例
           

摘要

Brain metastasis is an ominous complication of cancer, yet most cancer cells that infiltrate the brain die of unknown causes. Here, we identify plasmin from the reactive brain stroma as a defense against metastatic invasion, and plasminogen activator (PA) inhibitory serpins in cancer cells as a shield against this defense. Plasmin suppresses brain metastasis in two ways: by converting membrane-bound astrocytic FasL into a paracrine death signal for cancer cells, and by inactivating the axon pathfinding molecule L1CAM, which metastatic cells express for spreading along brain capillaries and for metastatic outgrowth. Brain metastatic cells from lung cancer and breast cancer express high levels of anti-PA serpins, including neuroserpin and serpin B2, to prevent plasmin generation and its metastasis-suppressive effects. By protecting cancer cells from death signals and fostering vascular co-option, anti-PA serpins provide a unifying mechanism for the initiation of brain metastasis in lung and breast cancers.
机译:脑转移是癌症的不祥并发症,但大多数浸入脑的癌细胞会死于未知原因。在这里,我们从反应性脑基质中识别纤溶酶来防御转移性侵袭,并在癌细胞中抑制纤溶酶原激活剂(PA)的丝氨酸蛋白酶抑制这种防御。纤溶酶通过两种方式抑制脑转移:通过将膜结合的星形细胞FasL转化为癌细胞的旁分泌死亡信号,以及通过使轴突寻路分子L1CAM失活,该轴突寻路分子表达为沿脑毛细血管扩散和转移性生长而表达。来自肺癌和乳腺癌的脑转移细胞表达高水平的抗PA丝氨酸蛋白酶抑制剂,包括神经丝氨酸蛋白酶抑制剂和丝氨酸蛋白酶抑制剂B2,以防止纤溶酶的产生及其转移抑制作用。通过保护癌细胞免受死亡信号的侵害并促进血管共存选择,抗PA丝氨酸蛋白酶抑制剂为肺癌和乳腺癌中脑转移的启动提供了统一的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号